Kindred Healthcare, Inc. (NYSE:KND) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Kindred Healthcare has set its FY18 guidance at approx $0.80 EPS.
Kindred Healthcare (NYSE:KND) last announced its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.03. Kindred Healthcare had a negative return on equity of 80.03% and a negative net margin of 7.06%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company earned $0.38 EPS. The firm’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, analysts expect Kindred Healthcare to post $0.22 EPS for the current fiscal year and $0.67 EPS for the next fiscal year.
Shares of Kindred Healthcare, Inc. (NYSE KND) traded up 3.42% during mid-day trading on Tuesday, reaching $6.05. The company had a trading volume of 781,677 shares. The company’s market capitalization is $526.46 million. Kindred Healthcare, Inc. has a 12 month low of $5.50 and a 12 month high of $11.90. The firm’s 50-day moving average is $6.50 and its 200 day moving average is $8.84.
A number of equities analysts have weighed in on the company. BidaskClub downgraded Kindred Healthcare from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 8th. Zacks Investment Research raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, August 11th. Mizuho reissued a “neutral” rating and set a $9.00 price target on shares of Kindred Healthcare in a research report on Monday, July 3rd. Bank of America Corp lowered their price target on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating on the stock in a research report on Thursday, September 21st. Finally, Royal Bank Of Canada lowered their price target on Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating on the stock in a research report on Thursday, September 21st. Six equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. Kindred Healthcare presently has a consensus rating of “Hold” and a consensus price target of $8.75.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
What are top analysts saying about Kindred Healthcare Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Kindred Healthcare Inc. and related companies.